首页 > 最新文献

Journal of Neurointensive Care最新文献

英文 中文
Clinical Analyses of Traumatic Cervical Spinal Cord Injury Patients Treated in the Intensive Care Unit 重症监护室外伤性颈脊髓损伤的临床分析
Pub Date : 2022-04-30 DOI: 10.32587/jnic.2021.00451
J. Han, Se-Hoon Kim, J. Choi, Sung-Kon Ha, Sang-Dae Kim, D. Lim, Bum-Joon Kim
Objective: Patients with spinal cord injury (SCI) are often unstable and require intensive care unit (ICU) treatment in the acute phase. This study assists in the prognosis and treatment direction of SCI patients by retrospectively examining and analyzing the clinical characteristics of SCI patients admitted to the ICU.Methods: In this study, a total of 102 SCI patients were admitted to the ICU of our hospital from February 2013 to March 2019. Based on the medical records, the patient's gender, age, mechanism of injuries, day of hospitalization, surgery timing, tracheostomy, ventilator use, steroid use, underlying disease, and hypotension were investigated. To assess the clinical outcome, the american spinal injury association (ASIA) impairment scale and limb motor grade three weeks and six months after injury was evaluated.Results: Of the 102 patients, 76 (74.51%) were male, and the average age was 57.57 years. Of these, 87 (85.29%) had spinal surgery, while 30 (34.48%) had surgery within 36 h after injury. High doses of steroids were administered in 15 patients (14.85%). As for the ASIA impairment scale, Grade A at the initial stage of injury reached 15% of all patients but decreased to 5.1% after three weeks and 1.9% after six months.Conclusion: Early surgery was advantageous in improving the lower extremity motor grade at three weeks of injury. Although steroid use has no significant effect compared to the risk of complications in several previous studies, in this study, it was observed that the ASIA scale improved six months after injury in patients receiving high-dose steroids.
目的:脊髓损伤(SCI)患者往往不稳定,在急性期需要重症监护病房(ICU)治疗。本研究通过对ICU收治的SCI患者的临床特征进行回顾性分析,为脊髓损伤患者的预后和治疗方向提供帮助。方法:本研究选取2013年2月至2019年3月我院ICU收治的102例SCI患者。根据病历,调查患者的性别、年龄、损伤机制、住院天数、手术时间、气管切开术、呼吸机使用、类固醇使用、基础疾病和低血压。为了评估临床结果,对损伤后3周和6个月的美国脊髓损伤协会(ASIA)损伤量表和肢体运动等级进行评估。结果:102例患者中,男性76例(74.51%),平均年龄57.57岁。其中87例(85.29%)行脊柱手术,30例(34.48%)在损伤后36 h内行手术。15例患者(14.85%)使用高剂量类固醇。ASIA损伤量表中,损伤初期A级占所有患者的15%,3周后降至5.1%,6个月后降至1.9%。结论:早期手术有利于改善损伤后3周的下肢运动等级。虽然在之前的几项研究中,类固醇的使用对并发症的风险没有显著影响,但在本研究中,我们观察到接受大剂量类固醇的患者在受伤后6个月的ASIA评分有所改善。
{"title":"Clinical Analyses of Traumatic Cervical Spinal Cord Injury Patients Treated in the Intensive Care Unit","authors":"J. Han, Se-Hoon Kim, J. Choi, Sung-Kon Ha, Sang-Dae Kim, D. Lim, Bum-Joon Kim","doi":"10.32587/jnic.2021.00451","DOIUrl":"https://doi.org/10.32587/jnic.2021.00451","url":null,"abstract":"Objective: Patients with spinal cord injury (SCI) are often unstable and require intensive care unit (ICU) treatment in the acute phase. This study assists in the prognosis and treatment direction of SCI patients by retrospectively examining and analyzing the clinical characteristics of SCI patients admitted to the ICU.Methods: In this study, a total of 102 SCI patients were admitted to the ICU of our hospital from February 2013 to March 2019. Based on the medical records, the patient's gender, age, mechanism of injuries, day of hospitalization, surgery timing, tracheostomy, ventilator use, steroid use, underlying disease, and hypotension were investigated. To assess the clinical outcome, the american spinal injury association (ASIA) impairment scale and limb motor grade three weeks and six months after injury was evaluated.Results: Of the 102 patients, 76 (74.51%) were male, and the average age was 57.57 years. Of these, 87 (85.29%) had spinal surgery, while 30 (34.48%) had surgery within 36 h after injury. High doses of steroids were administered in 15 patients (14.85%). As for the ASIA impairment scale, Grade A at the initial stage of injury reached 15% of all patients but decreased to 5.1% after three weeks and 1.9% after six months.Conclusion: Early surgery was advantageous in improving the lower extremity motor grade at three weeks of injury. Although steroid use has no significant effect compared to the risk of complications in several previous studies, in this study, it was observed that the ASIA scale improved six months after injury in patients receiving high-dose steroids.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"101 10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125971500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurosurgical Complications in Patients with Nasopharyngeal Cancer Accompanied by Skull Base Erosion: A case report 鼻咽癌伴颅底侵蚀患者的神经外科并发症1例报告
Pub Date : 2022-04-30 DOI: 10.32587/jnic.2022.00479
K. Lee, Byung Jun Kim, D. H. Park
A 66-year-old patient with nasopharyngeal cancer who had received chemotherapy and radiation therapy visited our emergency center with severe epistaxis. The patient was followed up with internal carotid artery trapping after a pseudoaneurysm was revealed in computed tomography angiography. Cerebrospinal fluid leakage was noted during follow-up observation after the intervention. This case presents various neurosurgical complications that can occur in patients with nasopharyngeal cancer.
一位66岁的鼻咽癌患者在接受化疗和放疗后因严重鼻出血来到我们的急诊中心。在计算机断层扫描血管造影中发现假性动脉瘤后,患者接受了颈内动脉夹闭的随访。干预后随访观察发现脑脊液漏。本病例呈现鼻咽癌患者可能出现的各种神经外科并发症。
{"title":"Neurosurgical Complications in Patients with Nasopharyngeal Cancer Accompanied by Skull Base Erosion: A case report","authors":"K. Lee, Byung Jun Kim, D. H. Park","doi":"10.32587/jnic.2022.00479","DOIUrl":"https://doi.org/10.32587/jnic.2022.00479","url":null,"abstract":"A 66-year-old patient with nasopharyngeal cancer who had received chemotherapy and radiation therapy visited our emergency center with severe epistaxis. The patient was followed up with internal carotid artery trapping after a pseudoaneurysm was revealed in computed tomography angiography. Cerebrospinal fluid leakage was noted during follow-up observation after the intervention. This case presents various neurosurgical complications that can occur in patients with nasopharyngeal cancer.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132205101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Momentum: Scenarios in Patients with Neurotrauma 治疗势头:神经创伤患者的情况
Pub Date : 2022-04-30 DOI: 10.32587/jnic.2021.00430
Tariq Janjua, A. Agrawal, Y. Picón-Jaimes, I. Lozada‐Martínez, Berhioska Valentina Perez-Velasquez, Alejandra Mendoza-Ortiz, L. Moscote-Salazar
ment decisions can be clouded with the clinician’s personal biases or unrecognized acumen judgment errors. This translates to therapeutic momentum (TM). Therapeutic momentum was a term proposed by Rodrigo et al in 2012, they describe as: In situations when doctors do not stop or because of personal clinical decisions they do not interrupt therapeutic strategies without any benefit and contrary to evidence that supports maintaining treatment. In addition to the definition, we propose 2 classes of Therapeutic momentum: When the doctor has the deleterious effects of maintaining a therapy, and when the physician is unaware of the deleterious effects of maintaining a therapy. The concept of TM is strongly presented in the realm of traumatic brain injury (TBI). The examples of therapeutic momentum in BTI may include but are not limited to: fluid therapy (Hypertonic-Mannitol) without evidence of increased intracranial pressure, anticonvulsants keeping post-trauma antiepileptics for more than 7 days, gastroprotection (maintaining proton inhibitors without evidence of digestive tract bleeding), neuroimaging (performing control neuroimaging in unstable patients with no obvious clinical indication), and invasive intracranial pressure monitoring (maintaining intracranial pressure monitor when intracranial hypertension has resolved) We propose an algorithm for TM in circumstances where we consider strategies that are not effective in patients with TBI (Fig. 1). Truly the progression of TBI through the stages of care can lead to TM moments and each step deviation can lead the patient to a path of declined status. The moment of initial management includes optimization of perfusion pressure, airway control, avoid hypotension1), hypercarbia, correction of coagulopathy, control of temperature, and decision to proceed to surgery. Decompression after 48 hours if intracranial pressure (ICP) and cerebral perfusion pressure (CPP) can be controlled is the preferred pathway. Early decompression might be required from epidural hemorrhage, marked ICP not controlled with medical management, or obstructive hydrocephalus. Without trying medical management and going right to surgery might lead to unnecessary systemic Received: November 25, 2021 Accepted: December 30, 2021
治疗决定可能会受到临床医生个人偏见或未被认识到的敏锐判断错误的影响。这转化为治疗势头(TM)。治疗势头是Rodrigo等人在2012年提出的一个术语,他们将其描述为:在医生不停止或因为个人临床决定而不中断治疗策略的情况下,他们没有任何好处,与支持维持治疗的证据相反。除了定义之外,我们还提出了两类治疗动量:当医生有维持治疗的有害影响时,以及当医生没有意识到维持治疗的有害影响时。TM的概念在创伤性脑损伤(TBI)领域得到了广泛的应用。BTI中治疗势头的例子可能包括但不限于:液体治疗(高张力甘露醇)无颅内压升高的证据,抗惊厥药物使创伤后抗癫痫药物持续7天以上,胃保护(维持质子抑制剂,无消化道出血的证据),神经影像学(对无明显临床指征的不稳定患者进行对照神经影像学),在我们考虑对TBI患者无效的策略的情况下,我们提出了一种TM算法(图1)。确实,TBI在各个护理阶段的进展会导致TM时刻,每个步骤的偏差都会导致患者的状态下降。初始处理包括优化灌注压、气道控制、避免低血压、高碳化、纠正凝血功能障碍、控制体温和决定是否进行手术。如果能控制颅内压(ICP)和脑灌注压(CPP), 48h后减压是首选途径。硬膜外出血、明显的ICP未被药物控制或梗阻性脑积水可能需要早期减压。如果不尝试医疗管理,直接手术可能会导致不必要的系统性。收稿日期:2021年11月25日。接受日期:2021年12月30日
{"title":"Therapeutic Momentum: Scenarios in Patients with Neurotrauma","authors":"Tariq Janjua, A. Agrawal, Y. Picón-Jaimes, I. Lozada‐Martínez, Berhioska Valentina Perez-Velasquez, Alejandra Mendoza-Ortiz, L. Moscote-Salazar","doi":"10.32587/jnic.2021.00430","DOIUrl":"https://doi.org/10.32587/jnic.2021.00430","url":null,"abstract":"ment decisions can be clouded with the clinician’s personal biases or unrecognized acumen judgment errors. This translates to therapeutic momentum (TM). Therapeutic momentum was a term proposed by Rodrigo et al in 2012, they describe as: In situations when doctors do not stop or because of personal clinical decisions they do not interrupt therapeutic strategies without any benefit and contrary to evidence that supports maintaining treatment. In addition to the definition, we propose 2 classes of Therapeutic momentum: When the doctor has the deleterious effects of maintaining a therapy, and when the physician is unaware of the deleterious effects of maintaining a therapy. The concept of TM is strongly presented in the realm of traumatic brain injury (TBI). The examples of therapeutic momentum in BTI may include but are not limited to: fluid therapy (Hypertonic-Mannitol) without evidence of increased intracranial pressure, anticonvulsants keeping post-trauma antiepileptics for more than 7 days, gastroprotection (maintaining proton inhibitors without evidence of digestive tract bleeding), neuroimaging (performing control neuroimaging in unstable patients with no obvious clinical indication), and invasive intracranial pressure monitoring (maintaining intracranial pressure monitor when intracranial hypertension has resolved) We propose an algorithm for TM in circumstances where we consider strategies that are not effective in patients with TBI (Fig. 1). Truly the progression of TBI through the stages of care can lead to TM moments and each step deviation can lead the patient to a path of declined status. The moment of initial management includes optimization of perfusion pressure, airway control, avoid hypotension1), hypercarbia, correction of coagulopathy, control of temperature, and decision to proceed to surgery. Decompression after 48 hours if intracranial pressure (ICP) and cerebral perfusion pressure (CPP) can be controlled is the preferred pathway. Early decompression might be required from epidural hemorrhage, marked ICP not controlled with medical management, or obstructive hydrocephalus. Without trying medical management and going right to surgery might lead to unnecessary systemic Received: November 25, 2021 Accepted: December 30, 2021","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127368119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spinal Cord Reperfusion Injury after Decompression of Severe Cord Compression: Critical Care Management 严重脊髓压迫减压后脊髓再灌注损伤:重症监护管理
Pub Date : 2022-04-30 DOI: 10.32587/jnic.2021.00444
Tariq Janjua, Scott Myer, L. Moscote-Salazar
day, the MAP goal was relaxed and fluids were stopped. He was able to bear weight and take a few steps. The steroids were weaned off and Minocycline was restricted to a total of 7 days. He was discharged to the stroke unit followed by acute neurological rehabilitation. A for-mal and written informed consent was obtained from the patient for the publication of the case in-formation and images.
第二天,放松MAP目标并停止输液。他能承受重量并能走几步。停用类固醇,二甲胺四环素限用7天。他被送到中风病房,随后接受了急性神经康复治疗。从患者那里获得正式的书面知情同意,以发表病例信息和图像。
{"title":"Spinal Cord Reperfusion Injury after Decompression of Severe Cord Compression: Critical Care Management","authors":"Tariq Janjua, Scott Myer, L. Moscote-Salazar","doi":"10.32587/jnic.2021.00444","DOIUrl":"https://doi.org/10.32587/jnic.2021.00444","url":null,"abstract":"day, the MAP goal was relaxed and fluids were stopped. He was able to bear weight and take a few steps. The steroids were weaned off and Minocycline was restricted to a total of 7 days. He was discharged to the stroke unit followed by acute neurological rehabilitation. A for-mal and written informed consent was obtained from the patient for the publication of the case in-formation and images.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126823516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Kidney Injury Following Mannitol Infusion in Neurosurgical Patients 神经外科患者输注甘露醇后急性肾损伤
Pub Date : 2022-04-30 DOI: 10.32587/jnic.2021.00423
H. Choi, C. Yoon, J. Ryu
Background: To evaluate the acute kidney injury (AKI) predictors and their predictive performance during mannitol infusion, and the impact of AKI on in-hospital mortality of neurocritically ill patients.Methods: This was a retrospective, observational study of patients who were admitted at a tertiary university hospital, Seoul, Republic of Korea, neurosurgical intensive care unit (ICU) from January 2013 to December 2019. We included neurosurgical patients on mannitol infusion admitted in the ICU The primary endpoint was the occurrence of AKI.Results: A total of 3,964 patients were included in the final analysis. AKI was detected in 540 (13.6%) patients on mannitol infusion. Measured osmolality and osmolar gap were significantly higher in patients with AKI than those without (both p< 0.001). However, the predictive power of the two indicators was similar and were both weak predictors of AKI (both C-statistic <0.650). In the multivariable analysis, maximal measured osmolality, chronic kidney disease, Acute Physiology and Chronic Health Evaluation 2 score on ICU admission, use of vasopressor, use of glycerin, mechanical ventilation, and invasive ICP monitoring were significantly associated with AKI. In-hospital mortality was significantly higher in patients with AKI than those without (11.1% vs. 1.4%, p< 0.001).Conclusions: Based on our findings, kidney injury may be associated with poor clinical outcomes in neurosurgical and neurocritically ill patients, and monitoring serum osmolality and OG remains important in the prevention of kidney injury for patients on mannitol infusion. Moreover, clinical factors related to ICU management and pre-existing renal disease may aggravate AKI during mannitol infusion.
背景:评价甘露醇输注过程中急性肾损伤(AKI)的预测指标及其预测效果,以及AKI对神经危重症患者住院死亡率的影响。方法:对2013年1月至2019年12月在韩国首尔某大学附属医院神经外科重症监护病房(ICU)住院的患者进行回顾性观察性研究。我们纳入了在ICU接受甘露醇输注的神经外科患者,主要终点是AKI的发生。结果:共3964例患者纳入最终分析。甘露醇输注540例(13.6%)患者检出AKI。AKI患者的渗透压和渗透压间隙明显高于无AKI患者(p< 0.001)。然而,这两个指标的预测能力相似,都是AKI的弱预测指标(c统计量均<0.650)。在多变量分析中,最大渗透压测量值、慢性肾脏疾病、ICU入院时的急性生理和慢性健康评估2评分、血管加压剂的使用、甘油的使用、机械通气和有创ICP监测与AKI显著相关。AKI患者的住院死亡率显著高于无AKI患者(11.1% vs. 1.4%, p< 0.001)。结论:根据我们的研究结果,神经外科和神经危重症患者的肾损伤可能与较差的临床预后有关,监测血清渗透压和OG对于预防甘露醇输注患者的肾损伤仍然很重要。此外,与ICU管理和既往肾脏疾病相关的临床因素可能加重甘露醇输注期间的AKI。
{"title":"Acute Kidney Injury Following Mannitol Infusion in Neurosurgical Patients","authors":"H. Choi, C. Yoon, J. Ryu","doi":"10.32587/jnic.2021.00423","DOIUrl":"https://doi.org/10.32587/jnic.2021.00423","url":null,"abstract":"Background: To evaluate the acute kidney injury (AKI) predictors and their predictive performance during mannitol infusion, and the impact of AKI on in-hospital mortality of neurocritically ill patients.Methods: This was a retrospective, observational study of patients who were admitted at a tertiary university hospital, Seoul, Republic of Korea, neurosurgical intensive care unit (ICU) from January 2013 to December 2019. We included neurosurgical patients on mannitol infusion admitted in the ICU The primary endpoint was the occurrence of AKI.Results: A total of 3,964 patients were included in the final analysis. AKI was detected in 540 (13.6%) patients on mannitol infusion. Measured osmolality and osmolar gap were significantly higher in patients with AKI than those without (both p< 0.001). However, the predictive power of the two indicators was similar and were both weak predictors of AKI (both C-statistic <0.650). In the multivariable analysis, maximal measured osmolality, chronic kidney disease, Acute Physiology and Chronic Health Evaluation 2 score on ICU admission, use of vasopressor, use of glycerin, mechanical ventilation, and invasive ICP monitoring were significantly associated with AKI. In-hospital mortality was significantly higher in patients with AKI than those without (11.1% vs. 1.4%, p< 0.001).Conclusions: Based on our findings, kidney injury may be associated with poor clinical outcomes in neurosurgical and neurocritically ill patients, and monitoring serum osmolality and OG remains important in the prevention of kidney injury for patients on mannitol infusion. Moreover, clinical factors related to ICU management and pre-existing renal disease may aggravate AKI during mannitol infusion.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116129016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intensive Care Unit Management of Traumatic Brain Injury Patients 创伤性脑损伤患者的重症监护病房管理
Pub Date : 2022-04-30 DOI: 10.32587/jnic.2022.00486
Subhas K Konar, Indubala Maurya, D. Shukla, V. Maurya, Balachandar Deivasigamani, Priyadarshi Dikshit, Rakesh Mishra, A. Agrawal
Head injury or traumatic brain injury (TBI) is considered an instant epidemic in the developed world. Head injuries account for one quarter to a third of all trauma-related deaths. According to the Global Status Report on Road Safety 2018, more than 1.35 million people were killed in a single year. Out of these, 90% of the casualties occurred in developing countries, and India contributes about 11% of the total share. Until the last decade, cardiac disease, cancer, and road traffic accidents were considered the leading causes of death in our country. It is predicted that if the incidence of Road Traffic Accidents continues at the present rate, then by the end of 2025, the head injury will become the most common cause of death worldwide. The head injury patients pose a unique challenge to the treating physicians in the early period of hospitalization and the later duration of follow-up. The primary role of intensive care management is preventing and treating intracranial hypertension, which causes derangement in cerebral perfusion pressure (CPP), thereby preventing secondary brain injury. In the present review, we discuss the effective management of TBI in the critical care unit.
头部损伤或创伤性脑损伤(TBI)在发达国家被认为是一种即时流行病。头部受伤占所有创伤相关死亡的四分之一到三分之一。根据《2018年全球道路安全现状报告》,一年内有135多万人死亡。其中,90%的伤亡发生在发展中国家,而印度约占总份额的11%。直到最近十年,心脏病、癌症和道路交通事故被认为是我国死亡的主要原因。据预测,如果道路交通事故的发生率继续保持目前的速度,那么到2025年底,头部受伤将成为全世界最常见的死亡原因。颅脑损伤患者在住院早期和随访后期对治疗医师提出了独特的挑战。重症监护管理的主要作用是预防和治疗颅内高压,颅内高压引起脑灌注压紊乱,从而预防继发性脑损伤。在本综述中,我们讨论了在重症监护病房有效管理创伤性脑损伤。
{"title":"Intensive Care Unit Management of Traumatic Brain Injury Patients","authors":"Subhas K Konar, Indubala Maurya, D. Shukla, V. Maurya, Balachandar Deivasigamani, Priyadarshi Dikshit, Rakesh Mishra, A. Agrawal","doi":"10.32587/jnic.2022.00486","DOIUrl":"https://doi.org/10.32587/jnic.2022.00486","url":null,"abstract":"Head injury or traumatic brain injury (TBI) is considered an instant epidemic in the developed world. Head injuries account for one quarter to a third of all trauma-related deaths. According to the Global Status Report on Road Safety 2018, more than 1.35 million people were killed in a single year. Out of these, 90% of the casualties occurred in developing countries, and India contributes about 11% of the total share. Until the last decade, cardiac disease, cancer, and road traffic accidents were considered the leading causes of death in our country. It is predicted that if the incidence of Road Traffic Accidents continues at the present rate, then by the end of 2025, the head injury will become the most common cause of death worldwide. The head injury patients pose a unique challenge to the treating physicians in the early period of hospitalization and the later duration of follow-up. The primary role of intensive care management is preventing and treating intracranial hypertension, which causes derangement in cerebral perfusion pressure (CPP), thereby preventing secondary brain injury. In the present review, we discuss the effective management of TBI in the critical care unit.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121753865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Utility of Hemolung® in Acute Neurological Crisis with Ventilatory Failure Hemolung®在急性神经危重伴呼吸衰竭中的应用
Pub Date : 2022-04-28 DOI: 10.32587/jnic.2022.00458
Tariq Janjua, L. Moscote-Salazar
can be a help. A lower dose of anticoagulation infusion can be used to avoid any further hemorrhage in an active condition of intracranial hemorrhage 11) . Hemolung ® uses room airflow to remove CO 2 without a need for a high flow oxygen supply. This device will be useful in conditions as men-tioned with acute brain injury. In conclusion, we suggest that Hemolung ® device should be present in high capacity neurocritical care unit. Neurointensivist training and competency need to be maintained. Early inclusion of this de-Utility
可以帮上忙。在颅内出血的活动性情况下,低剂量的抗凝输注可避免进一步出血(11)。Hemolung®利用室内气流去除CO 2,无需高流量供氧。这个装置在急性脑损伤的情况下是有用的。综上所述,我们建议在高容量的神经危重症监护病房中使用Hemolung®装置。神经强化医师的训练和能力需要保持。早期包含此de-Utility
{"title":"Utility of Hemolung® in Acute Neurological Crisis with Ventilatory Failure","authors":"Tariq Janjua, L. Moscote-Salazar","doi":"10.32587/jnic.2022.00458","DOIUrl":"https://doi.org/10.32587/jnic.2022.00458","url":null,"abstract":"can be a help. A lower dose of anticoagulation infusion can be used to avoid any further hemorrhage in an active condition of intracranial hemorrhage 11) . Hemolung ® uses room airflow to remove CO 2 without a need for a high flow oxygen supply. This device will be useful in conditions as men-tioned with acute brain injury. In conclusion, we suggest that Hemolung ® device should be present in high capacity neurocritical care unit. Neurointensivist training and competency need to be maintained. Early inclusion of this de-Utility","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128055824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurotrauma Code: Proposal for the Implementation of Strategies in Areas of Difficult Care for a Time-dependent Condition. 神经创伤代码:时间依赖性疾病困难护理领域实施策略的建议。
Pub Date : 2022-04-28 DOI: 10.32587/jnic.2022.00472
L. Moscote-Salazar, Tariq Janjua, A. Pacheco-Hernandez
{"title":"Neurotrauma Code: Proposal for the Implementation of Strategies in Areas of Difficult Care for a Time-dependent Condition.","authors":"L. Moscote-Salazar, Tariq Janjua, A. Pacheco-Hernandez","doi":"10.32587/jnic.2022.00472","DOIUrl":"https://doi.org/10.32587/jnic.2022.00472","url":null,"abstract":"","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"193 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121198650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Creutzfeldt–Jakob Disease with Unusual Visual Hallucination : A Case Report 克雅氏病伴异常视幻觉1例报告
Pub Date : 2021-10-30 DOI: 10.32587/jnic.2021.00402
S. Rho, Hyo Joon Kim, Min Park
Initially described in 1921, Creutzfeldt-Jakob disease (CJD) is a rare, transmissible prion disease. There are four types of CJD known. Sporadic, familial, iatrogenic and variant, of which sporadic Creutzfeldt-Jakob disease (sCJD) is the most common, and sCJD has characteristic clinical and diagnostic features. It is a rapidly progressive, deadly infectious disease that usually results in death within a year of onset. The disease is thought to be caused by an abnormal isoform of a cellular glycoprotein known as prion protein, and is found in about 1 in 1 million people. Sporadic Creutzfeldt-Jakob disease, like other prion diseases, is classified as a transmissible spongiform encephalopathy and occurs as a sporadic disease without a recognizable transmission pattern in approximately 85% of patients. Current criteria for diagnosis include a distinct phenotype, periodic sharp and slow-wave complexes at electroencephalography (EEG), Clinical features seen in patients with sporadic Creutzfeldt-Jakob disease (sCJD) may be diverse symptoms. Due to diverse clinical features, it may be necessary to differentiate from cerebrovascular disease or psychotic symptoms during initial evaluation. In this case, we discuss the clinical case of a 57-year-old female patient with multiple neurological symptoms. The patient showed clinical features of alice in Wonderland syndrome during evaluation and conservative care, and was diagnosed with sCJD. In this regard, it is considered that evaluation and management are required along with recognition of the possibility of non-specific neurological symptoms such as AIWS in sCJD patients in the future.
克雅氏病(Creutzfeldt-Jakob disease, CJD)最初于1921年被发现,是一种罕见的传染性朊病毒疾病。目前已知的克雅氏病有四种。散发性、家族性、医源性和变异型,其中散发性克雅氏病(sCJD)最为常见,sCJD具有独特的临床和诊断特征。它是一种进展迅速的致命传染病,通常在发病一年内导致死亡。这种疾病被认为是由一种被称为朊蛋白的细胞糖蛋白的异常异构体引起的,大约百万分之一的人会发现这种疾病。散发性克雅氏病与其他朊病毒疾病一样,被归类为传染性海绵状脑病,在大约85%的患者中以散发性疾病的形式发生,没有可识别的传播模式。目前的诊断标准包括明显的表型,脑电图(EEG)周期性的锐波和慢波复合体。散发性克雅氏病(sCJD)患者的临床特征可能是多种症状。由于临床特征不同,在初步评估时可能需要与脑血管疾病或精神症状区分。在这种情况下,我们讨论的临床病例57岁的女性患者多发性神经症状。患者在评估和保守治疗中表现出爱丽丝梦游仙境综合征的临床特征,并被诊断为sCJD。在这方面,我们认为未来sCJD患者需要评估和管理,同时认识到AIWS等非特异性神经症状的可能性。
{"title":"Creutzfeldt–Jakob Disease with Unusual Visual Hallucination : A Case Report","authors":"S. Rho, Hyo Joon Kim, Min Park","doi":"10.32587/jnic.2021.00402","DOIUrl":"https://doi.org/10.32587/jnic.2021.00402","url":null,"abstract":"Initially described in 1921, Creutzfeldt-Jakob disease (CJD) is a rare, transmissible prion disease. There are four types of CJD known. Sporadic, familial, iatrogenic and variant, of which sporadic Creutzfeldt-Jakob disease (sCJD) is the most common, and sCJD has characteristic clinical and diagnostic features. It is a rapidly progressive, deadly infectious disease that usually results in death within a year of onset. The disease is thought to be caused by an abnormal isoform of a cellular glycoprotein known as prion protein, and is found in about 1 in 1 million people. Sporadic Creutzfeldt-Jakob disease, like other prion diseases, is classified as a transmissible spongiform encephalopathy and occurs as a sporadic disease without a recognizable transmission pattern in approximately 85% of patients. Current criteria for diagnosis include a distinct phenotype, periodic sharp and slow-wave complexes at electroencephalography (EEG), Clinical features seen in patients with sporadic Creutzfeldt-Jakob disease (sCJD) may be diverse symptoms. Due to diverse clinical features, it may be necessary to differentiate from cerebrovascular disease or psychotic symptoms during initial evaluation. In this case, we discuss the clinical case of a 57-year-old female patient with multiple neurological symptoms. The patient showed clinical features of alice in Wonderland syndrome during evaluation and conservative care, and was diagnosed with sCJD. In this regard, it is considered that evaluation and management are required along with recognition of the possibility of non-specific neurological symptoms such as AIWS in sCJD patients in the future.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132298997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Negative-Pressure Hydrocephalus Treated with a Modified Shunt System: A Case Report 改良分流系统治疗负压脑积水1例报告
Pub Date : 2021-10-30 DOI: 10.32587/jnic.2021.00374
H. Park, Sung Ho Lee, Chul-Kee Park, E. Ha
A negative-pressure hydrocephalus (NePH) is a rare type of hydrocephalus characterized by the presence of negative intracranial pressure (ICP) and ventriculomegaly. Despite the low or negative ICP, patients with NePH often develop symptoms consistent with high ICP, and they frequently deteriorate. Several hypotheses have been proposed to demonstrate the underlying pathophysiology in NePH, but the exact mechanism still remains unclear. Multiple treatment options have been suggested, including the identification and repair of cerebrospinal fluid (CSF) leak, subatmospheric external ventricular drains (EVD), neck wrapping, or placement of CSF shunts. In this study, we present a case of a NePH patient refractory to the standard CSF shunt procedure and successfully treated with a modified ventriculoperitoneal shunt system. A negative-pressure hydrocephalus (NePH) is a rare type of hydrocephalus that is symptomatic despite the negative intracranial pressure (ICP). Because of the shortcomings of the existing shunt system that could not produce the necessary gradient for an effective cerebrospinal fluid (CSF) drainage in NePH patients, a refined method for CSF drainage is needed. We combined the traditional low-pressure valve with a distal catheter, which has no end hole and only has side slits, to prevent the CSF backflow and facilitate the siphon effect. Simultaneously, the active pumping of the shunt reservoir was also conducted to remove the excess CSF from the ventricular system. The treatment of NePH requires an appropriate reduction of excessive CSF until the CSF dynamics and brain compliance are restored. We suggest the use of this modified shunt system for NePH treatment, as it is easily modifiable and has sufficient effects.
负压脑积水(NePH)是一种罕见的脑积水类型,其特征是存在负颅内压(ICP)和脑室肿大。尽管颅内压低或阴性,NePH患者经常出现与高颅内压一致的症状,并经常恶化。已经提出了几种假说来证明NePH的潜在病理生理学,但确切的机制仍然不清楚。多种治疗方案已被提出,包括脑脊液(CSF)泄漏的识别和修复,大气压下脑室外引流(EVD),颈部包裹,或放置脑脊液分流。在本研究中,我们报告了一例对标准脑脊液分流术难治的NePH患者,并成功地用改良的脑室-腹膜分流系统治疗。负压脑积水(NePH)是一种罕见的脑积水类型,尽管颅内压(ICP)为负,但仍有症状。由于现有分流系统的缺点,不能为NePH患者产生有效的脑脊液(CSF)引流所需的梯度,需要一种改进的脑脊液引流方法。我们将传统的低压阀与远端导管相结合,远端导管无端孔,只有侧缝,以防止脑脊液回流,促进虹吸效果。同时,分流水库的主动泵送也被进行,以清除多余的脑脊液从心室系统。治疗NePH需要适当减少过多的脑脊液,直到脑脊液动力学和脑顺应性恢复。我们建议使用这种改良的分流系统进行NePH治疗,因为它易于修改且效果充分。
{"title":"Negative-Pressure Hydrocephalus Treated with a Modified Shunt System: A Case Report","authors":"H. Park, Sung Ho Lee, Chul-Kee Park, E. Ha","doi":"10.32587/jnic.2021.00374","DOIUrl":"https://doi.org/10.32587/jnic.2021.00374","url":null,"abstract":"A negative-pressure hydrocephalus (NePH) is a rare type of hydrocephalus characterized by the presence of negative intracranial pressure (ICP) and ventriculomegaly. Despite the low or negative ICP, patients with NePH often develop symptoms consistent with high ICP, and they frequently deteriorate. Several hypotheses have been proposed to demonstrate the underlying pathophysiology in NePH, but the exact mechanism still remains unclear. Multiple treatment options have been suggested, including the identification and repair of cerebrospinal fluid (CSF) leak, subatmospheric external ventricular drains (EVD), neck wrapping, or placement of CSF shunts. In this study, we present a case of a NePH patient refractory to the standard CSF shunt procedure and successfully treated with a modified ventriculoperitoneal shunt system. A negative-pressure hydrocephalus (NePH) is a rare type of hydrocephalus that is symptomatic despite the negative intracranial pressure (ICP). Because of the shortcomings of the existing shunt system that could not produce the necessary gradient for an effective cerebrospinal fluid (CSF) drainage in NePH patients, a refined method for CSF drainage is needed. We combined the traditional low-pressure valve with a distal catheter, which has no end hole and only has side slits, to prevent the CSF backflow and facilitate the siphon effect. Simultaneously, the active pumping of the shunt reservoir was also conducted to remove the excess CSF from the ventricular system. The treatment of NePH requires an appropriate reduction of excessive CSF until the CSF dynamics and brain compliance are restored. We suggest the use of this modified shunt system for NePH treatment, as it is easily modifiable and has sufficient effects.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117062703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Neurointensive Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1